Elastomeric Infusion Pumps Market Outlook:
Elastomeric Infusion Pumps Market size was over USD 973.73 million in 2025 and is poised to exceed USD 1.95 billion by 2035, witnessing over 7.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of elastomeric infusion pumps is evaluated at USD 1.04 billion.
The increasing global prevalence of chronic illnesses is driving the market's expansion. The World Health Organization (WHO) issued numbers in September 2023 showing that non-communicable illnesses account for 74% of all deaths globally, killing 41 million people year. Non-communicable diseases claim the lives of 17 million people year before they turn 70, with low- and middle-income nations accounting for 86% of these early fatalities.
Worldwide demand for elastomeric infusion pumps is growing as a result of their affordability, versatility, and convenience of use when it comes to long-term medicine administration. Important developments include their use in home healthcare environments, increased acceptance of pain management, and the administration of chemotherapy and antibiotics outside of conventional hospital settings.
Moreover, advancements in elastomeric pump technology like enhanced accuracy and adjustable dosage contribute to their growing appeal on a worldwide scale.
